

8:30 am EDT - 12:30 pm EDT
Past Event
8:30 am - 12:30 pm EDT
1135 16th St, NW
Washington, DC
20036
On June 13, 2008, the Engelberg Center for Health Care Reform hosted a public forum on prescription drug safety and post-market evidence. This public event included a brief overview of current Food and Drug Administration (FDA) activity concerning drug safety; a discussion of a broad-based approach to generating a distributed data network for post-market evidence; and a review of progress to date on a host of technical, legal, and communications-related challenges identified in the course of our ongoing collaborative work in this area.
Mark McClellan, Director of the Engelberg Center for Health Care Reform and Leonard D. Schaeffer Chair in Health Policy Studies at the Brookings Institution, provided introductory remarks and helped moderate this discussion among many of today’s leading health care policy-makers and analysts.
Read full event summary »
Meeting Materials:
Agenda »
Panelists’ Slide Presentations »
Drug Safety Collaboration Legal Guidance Document »
Sentinel Project Handout »
8:30 am - 12:30 pm
The Engelberg Center for Health Care Reform hosted a public forum on prescription drug safety that included a brief overview of current Food and Drug Administration activity as well as progress to date on a host of technical, legal and communications-related challenges identified in the course of the center’s ongoing collaborative work in this area.
Matthew Fiedler
January 31, 2025
Richard G. Frank
January 30, 2025
Rachel Sachs, Richard G. Frank
January 29, 2025